Montenegro vs Slovenia: The number of people with susceptibility test result for rifampicin
Montenegro
55
in 2021
Slovenia
58
in 2021
Montenegro rank
121st
Slovenia rank
119th
The number of people with susceptibility test result for rifampicin over time
- Montenegro
- Slovenia
How they compare
Slovenia currently reports 58 against 55 in Montenegro, a difference of 3.
That makes Slovenia's figure about 1.1 times Montenegro's.
Across all 5 years both countries report, Slovenia has been ahead every year.
Montenegro ranks 121st and Slovenia ranks 119th of 155 countries.
Slovenia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Montenegro | Slovenia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 57 | 77.67 | 20.67 | Slovenia |
| 2020s | 42 | 57.5 | 15.5 | Slovenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Montenegro or Slovenia?
- Slovenia, at 58 against 55 in Montenegro as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Montenegro and Slovenia?
- 3, with Slovenia ahead.
- How many years of comparable data are there for Montenegro and Slovenia?
- 5 years are reported by both, from 2017 to 2021.
- How do Montenegro and Slovenia rank globally for the number of people with susceptibility test result for rifampicin?
- Montenegro ranks 121st and Slovenia ranks 119th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.